skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 260  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: Journal Title: Bmc Cancer remove subject: Cancer Therapies remove subject: Patients remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study
Material Type:
Article
Add to My Research

Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study

BMC cancer, 2017-05, Vol.17 (1), p.332-332, Article 332 [Peer Reviewed Journal]

COPYRIGHT 2017 BioMed Central Ltd. ;COPYRIGHT 2017 BioMed Central Ltd. ;Copyright BioMed Central 2017 ;The Author(s). 2017 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-017-3286-5 ;PMID: 28511673

Full text available

2
Induction chemotherapy combined with immunotherapy in locally advanced head and neck squamous cell carcinoma
Material Type:
Article
Add to My Research

Induction chemotherapy combined with immunotherapy in locally advanced head and neck squamous cell carcinoma

BMC cancer, 2021-05, Vol.21 (1), p.1-622, Article 622 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-08373-8 ;PMID: 34044810

Full text available

3
Use of Bevacizumab in recurrent glioblastoma: a scoping review and evidence map
Material Type:
Article
Add to My Research

Use of Bevacizumab in recurrent glioblastoma: a scoping review and evidence map

BMC cancer, 2023-06, Vol.23 (1), p.544-544, Article 544 [Peer Reviewed Journal]

2023. The Author(s). ;COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11043-6 ;PMID: 37316802

Full text available

4
Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment
Material Type:
Article
Add to My Research

Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment

BMC cancer, 2022-04, Vol.22 (1), p.368-368, Article 368 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09439-x ;PMID: 35392843

Full text available

5
A specific gene expression signature for visceral organ metastasis in breast cancer
Material Type:
Article
Add to My Research

A specific gene expression signature for visceral organ metastasis in breast cancer

BMC cancer, 2019-04, Vol.19 (1), p.333-333, Article 333 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-5554-z ;PMID: 30961553

Full text available

6
A novel ferroptosis-related lncRNA signature for prognosis prediction in gastric cancer
Material Type:
Article
Add to My Research

A novel ferroptosis-related lncRNA signature for prognosis prediction in gastric cancer

BMC cancer, 2021-11, Vol.21 (1), p.1221-1221, Article 1221 [Peer Reviewed Journal]

2021. The Author(s). ;COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-08975-2 ;PMID: 34774009

Full text available

7
A nomogram prediction model for lymph node metastasis in endometrial cancer patients
Material Type:
Article
Add to My Research

A nomogram prediction model for lymph node metastasis in endometrial cancer patients

BMC cancer, 2021-06, Vol.21 (1), p.1-748, Article 748 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-08466-4 ;PMID: 34187416

Full text available

8
INHBA is a prognostic predictor for patients with colon adenocarcinoma
Material Type:
Article
Add to My Research

INHBA is a prognostic predictor for patients with colon adenocarcinoma

BMC cancer, 2020-04, Vol.20 (1), p.305-305, Article 305 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-06743-2 ;PMID: 32293338

Full text available

9
Advances in personalized radiotherapy
Material Type:
Article
Add to My Research

Advances in personalized radiotherapy

BMC cancer, 2024-05, Vol.24 (1), p.556-556 [Peer Reviewed Journal]

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12317-3 ;PMID: 38702617

Full text available

10
Nomogram for predicting the survival of gastric adenocarcinoma patients who receive surgery and chemotherapy
Material Type:
Article
Add to My Research

Nomogram for predicting the survival of gastric adenocarcinoma patients who receive surgery and chemotherapy

BMC cancer, 2020-01, Vol.20 (1), p.10-10, Article 10 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2020 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-6495-2 ;PMID: 31906882

Full text available

11
Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study
Material Type:
Article
Add to My Research

Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study

BMC cancer, 2020-07, Vol.20 (1), p.614-13, Article 614 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-07087-7 ;PMID: 32611327

Full text available

12
Overall survival following stereotactic radiosurgery for ten or more brain metastases: a systematic review and meta-analysis
Material Type:
Article
Add to My Research

Overall survival following stereotactic radiosurgery for ten or more brain metastases: a systematic review and meta-analysis

BMC cancer, 2023-10, Vol.23 (1), p.1-1004, Article 1004 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;BioMed Central Ltd., part of Springer Nature 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11452-7

Full text available

13
Prognostic potential of preoperative circulating tumor cells to predict the early progression recurrence in hepatocellular carcinoma patients after hepatectomy
Material Type:
Article
Add to My Research

Prognostic potential of preoperative circulating tumor cells to predict the early progression recurrence in hepatocellular carcinoma patients after hepatectomy

BMC cancer, 2023-11, Vol.23 (1), p.1-1150, Article 1150 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11629-0

Full text available

14
Prognostic value of platelet distribution width to lymphocyte ratio in patients with hepatocellular carcinoma following hepatectomy
Material Type:
Article
Add to My Research

Prognostic value of platelet distribution width to lymphocyte ratio in patients with hepatocellular carcinoma following hepatectomy

BMC cancer, 2023-11, Vol.23 (1), p.1-1116, Article 1116 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11621-8

Full text available

15
Comparison of 3 and 4 cycles of neoadjuvant gemcitabine and cisplatin for muscle-invasive bladder cancer: a systematic review and meta-analysis
Material Type:
Article
Add to My Research

Comparison of 3 and 4 cycles of neoadjuvant gemcitabine and cisplatin for muscle-invasive bladder cancer: a systematic review and meta-analysis

BMC cancer, 2023-11, Vol.23 (1), p.1-1066, Article 1066 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11572-0

Full text available

16
Prognostic impact of pretreatment skeletal muscle index and CONUT score in diffuse large B-cell Lymphoma
Material Type:
Article
Add to My Research

Prognostic impact of pretreatment skeletal muscle index and CONUT score in diffuse large B-cell Lymphoma

BMC cancer, 2023-11, Vol.23 (1), p.1-1071, Article 1071 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11590-y ;PMID: 37932700

Full text available

17
Development of a well-defined tool to predict the overall survival in lung cancer patients: an African based cohort
Material Type:
Article
Add to My Research

Development of a well-defined tool to predict the overall survival in lung cancer patients: an African based cohort

BMC cancer, 2023-10, Vol.23 (1), p.1-1016, Article 1016 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;BioMed Central Ltd., part of Springer Nature 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11355-7 ;PMID: 37864151

Full text available

18
Analysis of neoadjuvant chemotherapy for breast cancer: a 20-year retrospective analysis of patients of a single institution
Material Type:
Article
Add to My Research

Analysis of neoadjuvant chemotherapy for breast cancer: a 20-year retrospective analysis of patients of a single institution

BMC cancer, 2023-10, Vol.23 (1), p.1-984, Article 984 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;BioMed Central Ltd., part of Springer Nature 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11505-x

Full text available

19
Online decision tools for personalized survival prediction and treatment optimization in elderly patients with lung squamous cell carcinoma: a retrospective cohort study
Material Type:
Article
Add to My Research

Online decision tools for personalized survival prediction and treatment optimization in elderly patients with lung squamous cell carcinoma: a retrospective cohort study

BMC cancer, 2023-09, Vol.23 (1), p.1-920, Article 920 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;BioMed Central Ltd., part of Springer Nature 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11309-z ;PMID: 37773106

Full text available

20
Patient-reported outcomes in individuals with advanced gastrointestinal stromal tumor treated with ripretinib in the fourth-line setting: analysis from the phase 3 INVICTUS trial
Material Type:
Article
Add to My Research

Patient-reported outcomes in individuals with advanced gastrointestinal stromal tumor treated with ripretinib in the fourth-line setting: analysis from the phase 3 INVICTUS trial

BMC cancer, 2022-12, Vol.22 (1), p.1302-10 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-10379-9 ;PMID: 36514034

Full text available

Results 1 - 20 of 260  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2013  (3)
  2. 2013 To 2016  (8)
  3. 2017 To 2018  (7)
  4. 2019 To 2021  (153)
  5. After 2021  (90)
  6. More options open sub menu

Searching Remote Databases, Please Wait